Claire McLintock
#148,805
Most Influential Person Now
New Zealand haematologist and obstetric physician
Claire McLintock's AcademicInfluence.com Rankings
Claire McLintockphilosophy Degrees
Philosophy
#12011
World Rank
#16618
Historical Rank
Logic
#8829
World Rank
#11097
Historical Rank
Download Badge
Philosophy
Claire McLintock's Degrees
- Masters Medicine University of Auckland
Why Is Claire McLintock Influential?
(Suggest an Edit or Addition)According to Wikipedia, Marie Claire McLintock was a New Zealand haematologist and obstetric physician. She was an expert in medical conditions and disorders related to bleeding and blood clotting, and medical problems associated with pregnancy.
Claire McLintock's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) (1949)
- Guidelines for the management of hypertensive disorders of pregnancy 2008 (2009) (289)
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. (2018) (257)
- Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study (2010) (244)
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
- Evaluation and management of postpartum hemorrhage: consensus from an international expert panel (2014) (192)
- Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin (2009) (161)
- Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. (2009) (151)
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. (2021) (142)
- New oral anticoagulants: a practical guide on prescription, laboratory testing and peri‐procedural/bleeding management (2014) (128)
- Inherited thrombophilia and pregnancy complications revisited. (2008) (111)
- Recombinant Activated Factor VII in Obstetric Hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry (2009) (110)
- Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. (2011) (106)
- Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period (2012) (102)
- Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage (2008) (98)
- Obstetric hemorrhage (2011) (91)
- Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. (2011) (74)
- Recommendations for the prevention of pregnancy‐associated venous thromboembolism (2012) (69)
- Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial (2017) (62)
- Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial (2017) (62)
- Postpartum hemorrhage: When uterotonics and sutures fail (2012) (61)
- Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case–control study (2017) (58)
- Obstetric haemorrhage. (2009) (57)
- A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID‐19 (2020) (55)
- Inherited thrombophilias are not increased in "idiopathic" small-for-gestational-age pregnancies. (2003) (52)
- Maternal super-obesity and perinatal outcomes in Australia: a national population-based cohort study (2015) (50)
- Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes and monitoring (2003) (47)
- Thrombocytopenia and disorders of platelet function in pregnancy. (2011) (43)
- RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19 (2020) (40)
- Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes. (2013) (37)
- Amniotic fluid embolism: an Australian-New Zealand population-based study (2015) (35)
- Anticoagulation practice patterns in COVID‐19: A global survey (2020) (32)
- Review of contributory factors in maternity admissions to intensive care at a New Zealand tertiary hospital. (2013) (32)
- Critical illness with AH1N1v influenza in pregnancy: a comparison of two population‐based cohorts (2011) (30)
- Early detection of severe maternal morbidity: A retrospective assessment of the role of an Early Warning Score System (2014) (29)
- Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. (2014) (29)
- Inherited thrombophilia and stillbirth. (2002) (27)
- Managing ITP and thrombocytopenia in pregnancy (2020) (25)
- Erratum: Inherited thrombophilia and pregnancy complications revisited (Obstetrics & Gynecology (2008) 112 (320-324)) (2008) (24)
- Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves (2016) (22)
- Ethical issues: The multi‐centre low‐risk ethics/governance review process and AMOSS (2012) (21)
- The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high‐income setting: a prospective cohort study (2020) (21)
- Prophylactic anticoagulation for patients in hospital with covid-19 (2021) (19)
- Inherited thrombophilias: implications for pregnancy-associated venous thromboembolism and obstetric complications (2001) (18)
- Rheumatic heart disease in pregnancy: How can health services adapt to the needs of Indigenous women? A qualitative study (2018) (18)
- Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries (2021) (16)
- Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy‐associated venous thromboembolism (2019) (16)
- The Australasian Maternity Outcomes Surveillance System: An evaluation of stakeholder engagement, usefulness, simplicity, acceptability, data quality and stability (2013) (14)
- Erratum: Evaluation and management of postpartum hemorrhage: Consensus from an international expert panel (Transfusion (2014) 54 (1756-1768)) (2015) (13)
- Women with bleeding disorders: Clinical and psychological issues (2018) (13)
- Maternal and fetal outcomes of primary immune thrombocytopenia during pregnancy: A retrospective study (2017) (13)
- International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis (2016) (13)
- von Willebrand disease: proposing definitions for future research. (2021) (12)
- Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management. (2020) (11)
- Hemophilia gene therapy knowledge and perceptions: Results of an international survey (2020) (11)
- von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis (2021) (10)
- How I Treat Lymphoma in Pregnancy. (2020) (9)
- Illustrated State‐of‐the‐Art Capsules of the ISTH 2019 Congress in Melbourne, Australia (2019) (9)
- Global public awareness about atrial fibrillation (2017) (9)
- Guidelines for the Use of Recombinant Activated Factor VII in Massive Obstetric Hemorrhage (2008) (9)
- An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta‐analysis (2021) (8)
- Thrombosis and Hemostasis Related Issues in Women and Pregnancy (2016) (6)
- Hematologic Disease in Pregnancy (2010) (6)
- Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol (2016) (5)
- Guidelines for the Management of Hypertensive Disorders of Pregnancy, 2008 (2010) (5)
- Menstruation, anticoagulation, and contraception: VTE and uterine bleeding (2021) (5)
- International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis (2019) (4)
- Use of therapeutic dose low molecular weight heparin during pregnancy in women with mechanical heart valves (2010) (4)
- 5: Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history (the eppi trial): an open-label international multicentre randomized controlled trial (2017) (4)
- A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing (2022) (4)
- Current practices of standardized risk assessment for venous thromboembolism: Results from a global survey from the World Thrombosis Day steering committee (2021) (4)
- Prosthetic heart valves and pregnancy. (2003) (4)
- HOW Collaborative position paper on the management of thrombocytopenia in pregnancy (2021) (4)
- Use of Blood Components in Major Obstetric Hemorrhage: Preliminary Findings from the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR) (2014) (4)
- Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. (2021) (4)
- Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy (2021) (3)
- Still casting its long shadow: rheumatic heart disease in Australia and New Zealand (2012) (3)
- Eclampsia in Australia and New Zealand: A prospective population-based study. (2019) (3)
- Avoiding adverse events with dabigatran by careful selection of eligible patients (2012) (3)
- The Spectrum, Severity and Outcomes of Rheumatic Mitral Valve Disease in Pregnant Women in Australia and New Zealand. (2021) (2)
- HRT, VTE and surgery: what is best practice? (2002) (2)
- International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis: reply (2016) (2)
- Anticoagulant options in pregnancy for women with mechanical valves (2017) (2)
- Hydroxyurea induced skin ulceration in myeloproliferative disorders. (2000) (2)
- World Thrombosis Day and prevention of hospital‐associated venous thromboembolism (2019) (2)
- Impact of World Thrombosis Day campaign (2017) (1)
- Prophylactic anticoagulation for patients in hospital with covid-19 (2021) (1)
- Postpartum haemorrhage. (2019) (1)
- Thromboprophylaxis in pregnant women: For whom and which LMWH dosage? Reply (2019) (1)
- Living through a pandemic – A time for clarity, courage and truth (2020) (1)
- Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day (2022) (1)
- Influenza AH1N1v in pregnancy (2011) (1)
- Perinatal outcomes of women with gestational breast cancer in Australia and New Zealand: A prospective population‐based study (2022) (1)
- Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study (2019) (1)
- Postpartum haemorrhage: a focus on haematological management (2011) (0)
- 2A.3 Post-partum hemorrhage (2007) (0)
- Challenges of Surveillance: Rheumatic Heart Disease (RHD) in Pregnancy (2013) (0)
- Peripartum Hemorrhage (2020) (0)
- [Peripheral ulcerative keratitis refractory to therapy in a young female patient]. (2019) (0)
- PT437 Working with health services: the AMOSS rheumatic heart disease (RHD) in pregnancy study (2014) (0)
- Unique Prospective Cohort Study: Rheumatic Heart Disease (RHD) and Pregnancy (2013) (0)
- PW356 Epidemiology of rheumatic heart disease (RHD) in pregnancy: Australia and New Zealand (2014) (0)
- The EPPI Trial ‐ Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history: an open‐label international multicentre randomised controlled trial (2017) (0)
- Thrombosis/thrombophilias and adverse pregnancy outcomes (2008) (0)
- Renal disease/preeclampsia and hypertension (2008) (0)
- Epidemiology of Rheumatic Heart Disease in Pregnancy in ANZ (2019) (0)
- The Obstetric Hematology Manual: Prosthetic heart valves (2010) (0)
This paper list is powered by the following services:
Other Resources About Claire McLintock
What Schools Are Affiliated With Claire McLintock?
Claire McLintock is affiliated with the following schools:
